High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 17, 2015, Pages 3187-3193

  Yang, L ^a   Bai, H S ^a,b   Deng, Y ^a   Fan, L ^a,c  

^a Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital   (China)

^b ZUNYI MEDICAL UNIVERSITY   (China)

^c SICHUAN CANCER HOSPITAL   (China)

Author keywords

Cervical cancer; Growth; Invasion.; MALAT1; Prognosis

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN;

ADULT; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CASKI CELL LINE; CELL INVASION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MTT ASSAY; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UTERINE CERVIX CANCER; AGED; CELL TRANSFORMATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; UTERINE CERVIX TUMOR;

ADULT; AGED; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RNA, LONG NONCODING; UTERINE CERVICAL NEOPLASMS;

EID: 84959255756     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. MUNAGALA R, KAUSAR H, MUNJAL C, GUPTA RC. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 2011; 32: 1697-1705.
3. DURST M, GISSMANN L, IKENBERG H, ZUR HAUSEN H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 1983; 80: 3812-3815.
4. PRENSNER JR, CHINNAIYAN AM. The emergence of lncRNAs in cancer biology. Cancer Discov 2011; 1: 391-407.
5. TSAI MC, SPITALE RC, CHANG HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011; 71: 3-7.
6. KORNIENKO AE, GUENZL PM, BARLOW DP, PAULER FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biol 2013; 11: 59.
7. XU S, JIN C, SHEN X, DING F, ZHU J, FU G. MicroR-NAs as potential novel therapeutic targets and tools for regulating paracrine function of endothelial progenitor cells. Med Sci Monit 2012; 18: HY27-31.
8. GIBB EA, BECKER-SANTOS DD, ENFIELD KS, GUILLAUD M, NIEKERK D, MATISIC JP, MACAULAY CE, LAM WL. Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia. Int J Gynecol Cancer 2012; 22: 1557-1563.
9. LI J, WANG Y, YU J, DONG R, QIU H. A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. Tumour Biol 2015; 36: 1661-1665.
10. CAO S, LIU W, LI F, ZHAO W, QIN C. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol 2014; 7: 6776-6783.
11. LIAO LM, SUN XY, LIU AW, WU JB, CHENG XL, LIN JX, ZHENG M, HUANG L. Low expression of long non-coding XLOC-010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer. Gynecol Oncol 2014; 133: 616-623.
12. JIANG Y, LI Y, FANG S, JIANG B, QIN C, XIE P, ZHOU G, LI G. The role of MALAT1 correlates with HPV in cervical cancer. Oncol Lett 2014; 7: 2135-2141.
13. GUO F, LI Y, LIU Y, WANG J, LI Y, LI G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai 2010; 42: 224-229.
14. JI Q, ZHANG L, LIU X, ZHOU L, WANG W, HAN Z, SUI H, TANG Y, WANG Y, LIU N, REN J, HOU F, LI Q. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 2014; 111: 736-748.
15. PANG EJ, YANG R, FU XB, LIU YF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 2015; 36: 2403-2407.
16. WANG J, SU L, CHEN X, LI P, CAI Q, YU B, LIU B, WU W, ZHU Z. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother 2014; 68: 557-564.
17. YANG MH, HU ZY, XU C, XIE LY, WANG XY, CHEN SY, LI ZG. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 2015; 1852: 166-174.
18. WU XS, WANG XA, WU WG, HU YP, LI ML, DING Q, WENG H, SHU YJ, LIU TY, JIANG L, CAO Y, BAO RF, MU JS, TAN ZJ, TAO F, LIU YB. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther 2014; 15: 806-814.
19. FAN Y, SHEN B, TAN M, MU X, QIN Y, ZHANG F, LIU Y. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Cancer Res 2014; 20: 1531-1541.
20. HIRATA H, HINODA Y, SHAHRYARI V, DENG G, NAKAJIMA K, TABATABAI ZL, ISHII N, DAHIYA R. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 2015; 75: 1322-1331.
21. WEBER DG, JOHNEN G, CASJENS S, BRYK O, PESCH B, JOCKEL KH, KOLLMEIER J, BRUNING T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of nonsmall cell lung cancer. BMC Res Notes 2013; 6: 518.
22. MA KX, WANG HJ, LI XR, LI T, SU G, YANG P, WU JW. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma. Tumour Biol 2015; 36: 3355-3359.